MedTrace Logo

Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository

NCT04574089 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-06-12

No results posted yet for this study

Summary

Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.To evaluate the efficacy and safety after treatment.

Conditions

  • Vaginitis

Interventions

DRUG

Experimental: Baofukang Suppository 7 days

Experimental: Baofukang Suppository 7 days

DRUG

Experimental: Baofukang Suppository 14 days

Experimental: Baofukang Suppository 14 days

Sponsors & Collaborators

  • Peking University Shenzhen Hospital

    lead OTHER

Principal Investigators

  • Shangrong Fan, M.D. · Dept of Obstetrics and Gynecology,Peking University Shenzhen Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2026-12-30
Completion
2026-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04574089 on ClinicalTrials.gov